12-45302107-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001025356.3(ANO6):c.150+14C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0251 in 1,610,344 control chromosomes in the GnomAD database, including 641 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.020 ( 42 hom., cov: 33)
Exomes 𝑓: 0.026 ( 599 hom. )
Consequence
ANO6
NM_001025356.3 intron
NM_001025356.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.306
Genes affected
ANO6 (HGNC:25240): (anoctamin 6) This gene encodes a multi-pass transmembrane protein that belongs to the anoctamin family. This protein is an essential component for the calcium-dependent exposure of phosphatidylserine on the cell surface. The scrambling of phospholipid occurs in various biological systems, such as when blood platelets are activated, they expose phosphatidylserine to trigger the clotting system. Mutations in this gene are associated with Scott syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 12-45302107-C-T is Benign according to our data. Variant chr12-45302107-C-T is described in ClinVar as [Benign]. Clinvar id is 257141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-45302107-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0197 (2995/152274) while in subpopulation NFE AF= 0.0308 (2097/68010). AF 95% confidence interval is 0.0297. There are 42 homozygotes in gnomad4. There are 1435 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 42 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANO6 | NM_001025356.3 | c.150+14C>T | intron_variant | ENST00000320560.13 | NP_001020527.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANO6 | ENST00000320560.13 | c.150+14C>T | intron_variant | 1 | NM_001025356.3 | ENSP00000320087 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0197 AC: 2995AN: 152158Hom.: 42 Cov.: 33
GnomAD3 genomes
AF:
AC:
2995
AN:
152158
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0191 AC: 4785AN: 251048Hom.: 71 AF XY: 0.0192 AC XY: 2602AN XY: 135666
GnomAD3 exomes
AF:
AC:
4785
AN:
251048
Hom.:
AF XY:
AC XY:
2602
AN XY:
135666
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0256 AC: 37382AN: 1458070Hom.: 599 Cov.: 30 AF XY: 0.0251 AC XY: 18217AN XY: 725624
GnomAD4 exome
AF:
AC:
37382
AN:
1458070
Hom.:
Cov.:
30
AF XY:
AC XY:
18217
AN XY:
725624
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0197 AC: 2995AN: 152274Hom.: 42 Cov.: 33 AF XY: 0.0193 AC XY: 1435AN XY: 74444
GnomAD4 genome
AF:
AC:
2995
AN:
152274
Hom.:
Cov.:
33
AF XY:
AC XY:
1435
AN XY:
74444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at